Fig. 5
From: Anti-cancer effects of lucidadiol against malignant melanoma cells
Lucidadiol inhibits the migration of B16 melanoma cells. A The effects of lucidadiol on B16 melanoma cell migration were quantified via a wound-healing assay for 12 and 24 h and statistical analysis of cell migration ability for each group is presented in the graph. B Representative blots of MMP-9 protein levels after treatment with lucidadiol (0 and 15 µM) for 0 and 48 h. The graph presents MMP-9 protein levels in B16 melanoma cells with/without lucidadiol treatment 48 h. The data are presented as the mean ± SD. *p < 0.05 when compared with the control group